Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TOMM40 pseudogene 2 (TOMM40P2) is classified as a pseudogene related to the protein-coding gene TOMM40, which encodes a channel-forming protein of the mitochondrial outer membrane involved in protein import[1][2]. Unlike TOMM40, TOMM40P2 does not encode a functional protein but can generate RNA transcripts that may modulate the transcription or regulation of its parental gene, TOMM40[1][2]. Pseudogene RNAs, including those from TOMM40P2 and related TOMM40 pseudogenes, have unclear and possibly diverse biological functions, including potential regulation of mitochondrial function and gene expression, but are not considered therapeutic targets, receptors, enzymes, or druggable entities[1][2]. There is currently no evidence of TOMM40P2 being a therapeutic target, receptor, or drug-binding entity, and no approved drugs or known direct disease associations; its relevance is limited to potential regulatory effects on mitochondrial biology through its similarity to TOMM40[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TOMM40 pseudogene 2 (TOMM40P2).